Infant formula containing serum protein concentrate
The use of serum protein concentrate in infant formulas addresses the mismatch in protein and amino acid profiles between bovine and human milk, ensuring legal amino acid levels are met with a lower protein content, promoting healthier growth patterns.
Patent Information
- Application Number
- JP2024530588
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-23
- Filing Date
- 2022-11-22
- Publication Date
- 2024-11-01
AI Technical Summary
Existing infant formulas based on bovine milk do not accurately replicate the protein composition and essential amino acid profile of human milk, leading to potential rapid weight gain and imbalanced body composition, despite efforts to meet legal amino acid requirements with higher protein content.
A formula using serum protein concentrate (SPC) as the primary source of amino acids, achieving a low protein content similar to human milk with a balanced casein/whey protein ratio, supplemented with bioactive components like lactoferrin and immunoglobulins, and optimized through microfiltration and ultrafiltration processes.
The SPC-based formula maintains essential amino acid concentrations meeting legal requirements while reducing overall protein content, promoting healthier weight gain and body composition, mimicking the nutritional profile of human milk.
Smart Images

Figure 2024540767000001 
Figure 2024540767000002 
Figure 2024540767000003
Abstract
Description
[Technical field]
[0001] The present invention relates to infant formulas containing serum protein concentrate. [Background technology]
[0002] The best nutrition to be provided to an infant is generally considered to be its own mother's milk, i.e. human milk. However, situations may arise where it is not possible to feed an infant with human milk. In such cases, cow's milk-based formulas are generally used to feed the infant. These formulas contain a mixture of casein and whey proteins, providing an amino acid profile as close as possible to that of human milk. Unfortunately, the protein composition of human milk and cow's milk differs substantially in both quantity and quality. A notable difference is the lower total protein content of human milk, which (i.e. the total nitrogen content multiplied by 6.25) is generally about 11 g / L, whereas that of cow's milk is about 33-35 g / L.
[0003] Human and cow's milk further differ in the types of proteins they contain. The total nitrogen-containing components in milk can be divided into pure protein nitrogen and non-protein nitrogen (NPN), with casein and serum proteins (also called whey proteins) as the major protein classes. Casein is a protein that precipitates at pH 4.6, while whey proteins remain soluble at this pH. In human milk, the whey protein to casein ratio varies from about 90:10 in the first days of life to about 60:40 in mature human milk, while in cow's milk the whey protein to casein ratio is about 20:80. The composition of casein and whey protein fractions also differs between human and cow's milk. The most abundant whey proteins in human milk are α-lactalbumin, lactoferrin and immunoglobulins, while the whey protein fraction of cow's milk contains about 50% β-lactoglobulin and about 15% α-lactalbumin. The most abundant casein in human milk is beta-casein, while cow's milk contains about 50% alpha-casein and about 35% beta-casein.
[0004] Another important difference is the relatively high content of essential amino acids in human milk: these amino acids cannot be synthesized by the human body and must be introduced into the body via food.
[0005] Formulas include infant formulas and follow-up formulas, which are capable of supplying the complete nutritional requirements of infants during the first month of life until the introduction of suitable complementary foods. There are legal requirements regulating the composition required for such formulas. One of these requirements is the minimum content of essential and some conditionally essential amino acids in line with the composition of human milk. See for example CODEX Alimentarus or EU Commission Directive 2016 / 127 / EC of 25 September 2015. To ensure minimum amounts of these (conditionally) essential amino acids, the protein content of conventional dairy-based formulas is significantly higher than the protein content of human milk. For example, a conventional source of protein in formula is a combination of milk powder or milk concentrate with a desalted whey protein concentrate, typically desalted cheese whey concentrate, which is added to bring the whey:casein ratio closer to that of human milk. To ensure the necessary content of essential amino acids, the total protein content of infant formulas generally ranges from 1.8 to 3.0 g / 100 kcal. The higher end of this range has the disadvantage, as shown by several studies, of causing rapid weight gain during the first year of life and potentially affecting body composition in older age. As a result, much research is underway towards infant formulas with lower total protein content without compromising the essential amino acid content. Examples of ways that this problem may be overcome include the addition of free amino acids, the use of casein glycomacropeptide (CMP) depleted whey, the addition of protein hydrolysates, and / or the use of alpha-lactalbumin enriched whey.
[0006] The present invention now provides a milk formula comprising serum protein concentrate (SPC) as the main, preferably sole, amino acid source, which allows the preparation of a low protein milk formula with a good essential amino acid profile and a casein / whey protein ratio close to that of human milk. The use of SPC also allows the preparation of a milk formula that can denature bioactive components such as lactoferrin and immunoglobulins with a minimal number of processing steps. Moreover, compared to cheese whey proteins, SPC does not naturally contain CMP, which is a cleavage product of κ-casein formed during cheese manufacture under the influence of the enzyme chymosin. CMP is rich in threonine, and its oligopeptide form allows the rapid absorption of threonine by the body, which can lead to overdosing causing hyperthreoninemia in premature infants. Moreover, high levels of CMP have a negative effect on the amino acid pattern, especially the amount of essential amino acids. Furthermore, SPC is rich in alpha-lactalbumin and beta-casein, which means that the overall protein composition of the claimed formulation more closely matches that of breast milk.
[0007] Serum protein concentrate (SPC), like whey protein concentrate (WPC), is the result of separating skim milk into a casein-rich fraction and a whey protein-rich fraction, followed by a concentration step. Whey protein concentrate (WPC) is a product obtained by ultrafiltration and / or reverse osmosis, and optional desalting, of acid whey (obtained by acidification of milk, i.e., casein production) or cheese whey (obtained by renneting, i.e., cheese manufacturing). Ultrafiltration removes most of the water, lactose and ash from the product, thereby concentrating the whey proteins. Reverse osmosis can be used to remove the water and further concentrate the WPC. On the other hand, the preparation of SPC involves the microfiltration of (skim) milk, which results in a concentrated (micellar) casein retentate and, as a permeate, a serum fraction containing most of the whey proteins. The serum protein fraction is also called ideal whey. Conventionally, this permeate is then subjected to ultrafiltration and / or reverse osmosis to remove lactose, ash and water.
[0008] Thus, the use of SPC as a whey protein source in formula is known.See, for example, WO 00 / 30461, WO 2008 / 127104 A1, WO 2013 / 068653 A2, and WO 2020 / 159356 A1.However, in addition to SPC, prior art formulas always contain a significant amount of at least one additional protein source, such as milk, micellar casein, or casein-rich microfiltration retentate. Summary of the Invention [Means for solving the problem]
[0009] The present invention relates to a milk formula wherein at least 90% by weight of the total amino acid content is obtained from serum protein concentrate, preferably at least 95% by weight, more preferably at least 99% by weight, most preferably 100% by weight. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] In a preferred embodiment, the formula has a low protein content of at most 2.3 g protein / 100 kcal, preferably at most 2.2, more preferably at most 2.1, even more preferably at most 2.0, more preferably at most 1.9 g protein / 100 kcal. The protein content of the formula is preferably at least 1.6 g protein / 100 kcal, more preferably at least 1.7, most preferably at least 1.8 g protein / kg 100 kcal.
[0011] Despite the low protein content and / or the SPC being (almost) the only source of amino acids, the concentration of essential amino acids meets the legal requirements. More specifically, the formula has the following essential amino acid composition: - L-methionine and L-cysteine with a combined concentration of at least 61 mg / 100 kcal, preferably in the range of 90-110 mg / 100 kcal, most preferably 100-110 mg / 100 kcal - L-tyrosine and L-phenylalanine with a combined concentration of at least 156 mg / 100 kcal, preferably in the range of 159-180 mg / 100 kcal, most preferably 160-170 mg / 100 kcal - at least 40 mg / 100 kcal, preferably 40-60 mg / 100 kcal, more preferably 45-55 mg / 100 kcal of L-histidine - at least 90 mg / 100 kcal, preferably 93-140 mg / 100 kcal, more preferably 100-140 mg / 100 kcal of L-isoleucine - at least 166 mg / 100 kcal, preferably 190-280 mg / 100 kcal, more preferably 230-280 mg / 100 kcal of L-leucine - at least 113 mg / 100 kcal, preferably 155-235 mg / 100 kcal, more preferably 180-235 mg / 100 kcal of L-lysine - at least 77 mg / 100 kcal, preferably 77-120 mg / 100 kcal, more preferably 95-120 mg / 100 kcal of L-threonine - at least 32 mg / 100 kcal, preferably 32-48 mg / 100 kcal, more preferably 40-48 mg / 100 kcal of L-tryptophan - at least 88 mg / 100 kcal, preferably 90-140 mg / 100 kcal, more preferably 110-140 mg / 100 kcal of L-valine.
[0012] In a preferred embodiment, the L-methionine content is at least 23 mg / 100 kcal, more preferably at least 40 mg / 100 kcal, and the L-cysteine content is at least 38 mg / 100 kcal, more preferably at least 50 mg / 100 kcal. In a further embodiment, the L-phenylalanine content is at least 81 mg / 100 kcal, more preferably 81-90 mg / 100 kcal, and the L-tyrosine content is at least 75 mg / 100 kcal, more preferably 75-85 mg / 100 kcal.
[0013] The whey protein:casein weight ratio in the SPC and in the infant formula is preferably in the range of 60:40 to 90:10, preferably 65:35 to 85:15, most preferably 70:30 to 80:20.
[0014] The beta-casein content of SPC is preferably in the range of 0-25% by weight, more preferably 5-20% by weight, most preferably 9-16% by weight. Beta-casein is rich in proline, which is a precursor for the formation of polyamines, which are synthesized in the body using ornithine as an intermediate.
[0015] The SPC preferably has the following amino acid content: - L-cysteine in the range of 2.0-3.0g / 100g protein, preferably 2.3-2.9g / 100g protein - L-histidine in the range of 2.0-3.0g / 100g protein, preferably 2.3-2.9g / 100g protein - L-Isoleucine in the range of 5.5-6.5g / 100g protein, preferably 5.8-6.4g / 100g protein - L-Leucine in the range of 12.0-13.0g / 100g protein, preferably 12.0-12.8g / 100g protein - L-lysine in the range of 9.5-10.5 g / 100 g protein, preferably 9.7-10.3 g / 100 g protein; - L-Methionine in the range of 2.5-3.0g / 100g protein, preferably 2.6-2.8g / 100g protein - L-phenylalanine in the range of 4.3-4.7g / 100g protein, preferably 4.4-4.6g / 100g protein - L-Threonine in the range of 5.0-5.5g / 100g protein, preferably 5.0-5.4g / 100g protein - L-Tyrosine in the range of 4.1-4.5g / 100g protein, preferably 4.1-4.3g / 100g protein - L-valine in the range of 6.0-6.5g / 100g protein, preferably 6.0-6.3g / 100g protein - L-tryptophan in the range of 2.0-2.5g / 100g protein, preferably 2.0-2.3g / 100g protein.
[0016] Such SPC can be prepared by microfiltration of (skimmed) milk, optionally diluted with water (water / milk volume ratio 0.5-1.5), using a 150-200 kDa microfiltration membrane and a temperature in the range of 10-20°C, preferably 10-15°C, most preferably 10-12°C. This temperature allows beta-casein permeation through the membrane. This microfiltration is followed by concentration of the serum-rich fraction by ultrafiltration using a 5-10 kDa membrane, also at a temperature in the range of 10-20° C., preferably 10-15° C., most preferably 10-12° C. Ultrafiltration removes water, lactose and minerals. The resulting UF retentate is SPC.
[0017] In a preferred embodiment, these filtrations are performed at 5000-8000 ml to tailor the protein fraction that permeates the membrane to obtain the desired amino acid profile. 2 , preferably 5200 to 7500 m 2 , more preferably 5400 to 7000 m 2 , most preferably 5400-6600m 2 Or 6200~7000m 2 The method is carried out using a total membrane surface area in the range of 0.01 mm to 0.2 mm (divided into several (e.g., 10 to 16) loops). Such a large membrane surface allows a more constant, i.e. less fluctuating, operating pressure, the pressure being the pressure against the membrane. The operating pressure preferably varies in the range of 0.8-3.5 bar, more preferably 0.2-3.0 bar, even more preferably 0.2-2.0 bar, even more preferably 0.2-1.0 bar, most preferably 0.8-1.3 bar.
[0018] The supply flow rate is preferably 16 to 19 m 3 / hour range. The flux over the membrane, i.e. the ratio between the product flow rate and the membrane surface area, is preferably relatively low, more preferably between 2 and 30, preferably between 2 and 10 l / m 2 / hr range. This allows only the smallest casein molecules to pass through the membrane, thereby resulting in a high whey protein to casein ratio. Microfiltration is preferably combined with diafiltration, more preferably with a ratio between diafiltration flow rate and membrane surface area of 2 to 30, preferably 2 to 10 l / m 2 / hour range. Cross flow on the membrane is 50 to 300 m 3 / hour range is preferred. The transmembrane pressure during microfiltration is preferably in the range of 0 to 4.0 bar, more preferably 0.8 to 3.5 bar, most preferably 0.8 to 1.3 bar. The transmembrane pressure during ultrafiltration is preferably in the range of 0 to 6.0 bar, more preferably 3.5 to 5.0 bar, most preferably 3.5 to 4.0 bar.
[0019] Prior to said microfiltration, and preferably between the optional skimming and said microfiltration, the milk may be subjected to a filtration step through a membrane allowing the survival of bacteria and the permeation of milk proteins, for example applying filtration through a ceramic membrane, for example a membrane with a pore size of about 1.4 μm.
[0020] A pasteurization step can be carried out during the process, which is preferably carried out before any filtration step, preferably after skimming the milk, or the SPC is pasteurized only after its preparation or incorporation into the nutritional composition.
[0021] Any conventional type of microfiltration membrane can be used, such as spiral, ceramic, hollow fiber, etc. Membranes can be constructed from a variety of polymer types, such as polysulfone (PS), (modified) polyethersulfone, polyvinylidene fluoride (PVDF), polyacrylonitrile (PAN), cellulose acetate (CA) and polypropylene (PP). Preferred ultrafiltration membranes are spiral-wound membranes, and even more preferred are hydrophilic polyethersulfone (PES) membranes.
[0022] If desired, the SPC may be further concentrated, desalted, and / or dried, for example by nanofiltration, ion exchange, electrodialysis, reverse osmosis, desalting, evaporation, and / or (spray) drying.
[0023] The total protein content is determined by the well-known Kjeldahl method (conversion factor 6.25). The amino acid content of the serum protein concentrate can be determined by ion exchange chromatography after hydrolysis according to ISO 13903:2005. Protein composition can be determined by reverse phase HPLC using hydrophobicity-based separation and UV detection. The casein content of SPC can be determined by precipitation at pH 4.6 using the method of ISO 17997 / DIF 29-1.
[0024] Formulas according to the invention can be prepared by combining SPC with at least a lipid source, a carbohydrate source, vitamins and minerals. The lipid source can be any lipid or fat suitable for use in formulas. Preferred fat sources include milk fat, safflower oil, egg yolk lipids, canola oil, olive oil, coconut oil, palm kernel oil, soybean oil, fish oil, palm olein, high oleic sunflower oil and high oleic safflower oil, as well as microbial fermentation oils containing long chain polyunsaturated fatty acids. In one embodiment, anhydrous milk fat is used. The lipid source can also be in the form of fractions derived from these oils, such as palm olein, medium chain triglycerides and esters of fatty acids (e.g., arachidonic acid, linoleic acid, palmitic acid, stearic acid, docosahexaenoic acid, linoleic acid, oleic acid, lauric acid, capric acid, caprylic acid, caproic acid, etc.). Small amounts of preformed arachidonic and docosahexaenoic acid rich oils (fish or microbial oils) may be added. The fat source preferably has a ratio of n-6 to n-3 fatty acids of about 5:1 to about 15:1, e.g., about 8:1 to about 10:1. In certain embodiments, the infant formula comprises an oil mixture that includes palmitic acid esterified to triacylglycerols, e.g., palmitic acid esterified to the sn-2 position of triacylglycerols in an amount of 20% to 60% by weight of the total palmitic acid and palmitic acid esterified to the sn-1 / sn-3 positions of triacylglycerols in an amount of 40% to 80% by weight of the total palmitic acid. Examples of vitamins and minerals which are preferably present in the formula are vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin E, vitamin K, vitamin C, vitamin D, folic acid, inositol, niacin, biotin, pantothenic acid, choline, calcium, phosphorus, iodine, iron, magnesium, copper, zinc, manganese, chloride, potassium, sodium, selenium, chromium, molybdenum, taurine and L-carnitine. Minerals are usually added in the form of their salts. Examples of carbohydrates that are preferably present in the formula are lactose, indigestible oligosaccharides such as galactooligosaccharides (GOS), fructooligosaccharides (FOS), inulin, xylooligosaccharides, and human milk oligosaccharides (HMO). Suitable HMOs include 2'FL, 3-FL, 3'-GL, 3'-SL, 6'-SL, LNT, LNnT, and combinations thereof. HMOs are commercially available or can be isolated from milk, in particular human breast milk. If necessary, the nutritional composition may contain emulsifiers and stabilizers, such as soy lecithin, citrate esters of mono- and diglycerides, etc. The nutritional composition may also contain other substances that may have beneficial effects, such as lactoferrin, nucleotides, nucleosides, probiotics, etc. Suitable probiotics include Lactobacteria, Bifidobacterium lactis, such as Bifidobacterium lactis Bb12, Streptococcus thermophilus, Lactobacillus johnsonii La1, Bifidobacterium longum BL999, Lactobacillus rhamnosus LPR, L. rhamnosus GG, Lactobacillus reuteri, Lactobacillus salivarius. Such prebiotics are commercially available.
[0025] Formulas are usually prepared for bottle- or cup-feeding from a powder (mixed with water) or liquid (with or without additional water). Formulas are commonly available as spray-dried powders. Spray drying involves an additional heating step. It is desirable to keep the heating conditions as gentle as possible during spray drying in order to preserve as much of the native protein as possible. To reduce the number of processing steps which may denature any proteins, it is preferred to dry blend the SPC with the other ingredients of the formula, or mix liquid SPC with the other liquid ingredients.
[0026] The formula according to the invention may be in the form of a dry, semi-dry or liquid composition, for example, the formula may be a powder composition suitable for making a liquid composition after reconstitution with an aqueous solution, preferably water. In another embodiment, the formula is a liquid composition, such as a ready-to-drink or spoonable composition. EXAMPLES
[0027] Example 1 Skim milk was filtered through a ceramic membrane at 50°C and pasteurized at 72°C for 15 seconds. The skim milk was then subjected to microfiltration and then ultrafiltration of the microfiltration permeate. Both were carried out at 15°C, for a total of 6200 ml 2 The MF+UF membrane surface area was used. The operating pressure varied from 0.8 to 1.3 bar during microfiltration and from 3.5 to 4.0 bar during ultrafiltration. During full run, the supply flow rate is 16.5m 3 It was / o'clock.
[0028] The resulting serum protein concentrate contained 65% protein by weight on dry solids.
[0029] The amino acid patterns of the obtained SPCs were determined according to ISO 13903:2005; the results are shown in Table 1. The table also lists the amino acid contents of an infant formula made with this SPC as the sole amino acid source and having a protein content of 1.9 g / 100 kcal, all of which are above the minimum amounts required by EU legislation.
[0030] [Table 1]
[0031] Comparative example A Total membrane surface area is 4828m 2 Example 1 was repeated, except that: The operating pressure varied more widely, from 0.8 to 3.5 during microfiltration and from 3.5 to 5.2 during ultrafiltration. The amino acid composition of the resulting SPC is shown in Table 2, which shows that the cysteine, leucine, lysine, threonine, and tryptophan content of this SPC is significantly lower than that of Example 1, and this SPC cannot be used as the sole amino acid source in infant formulas, especially in low protein infant formulas.
[0032] [Table 2]
Claims
1. The amino acid composition is: - L-cysteine in the range of 2.0-3.0 g / 100 g protein, preferably 2.3-2.9 g / 100 g protein L-histidine in the range of 2.0-3.0 g / 100 g protein, preferably 2.3-2.9 g / 100 g protein - L-isoleucine in the range of 5.5-6.5 g / 100 g protein, preferably 5.8-6.4 g / 100 g protein - L-leucine in the range of 12.0-13.0 g / 100 g protein, preferably 12.0-12.8 g / 100 g protein - L-lysine in the range of 9.5-10.5 g / 100 g protein, preferably 9.7-10.3 g / 100 g protein - L-methionine in the range of 2.5-3.0 g / 100 g protein, preferably 2.6-2.8 g / 100 g protein L-phenylalanine in the range of 4.3-4.7 g / 100 g protein, preferably 4.4-4.6 g / 100 g protein - L-threonine in the range of 5.0-5.5 g / 100 g protein, preferably 5.0-5.4 g / 100 g protein - L-tyrosine in the range of 4.1-4.5 g / 100 g protein, preferably 4.1-4.3 g / 100 g protein - L-valine in the range of 6.0-6.5 g / 100 g protein, preferably 6.0-6.3 g / 100 g protein - L-tryptophan in the range of 2.0-2.5 g / 100 g protein, preferably 2.0-2.3 g / 100 g protein A serum protein concentrate having
2. 13. Use of the serum protein concentrate according to claim 1 in infant formula.
3. 2. A process for producing a serum protein concentrate according to claim 1, comprising the steps of microfiltration of milk using a 150-200 kDa membrane resulting in a casein-rich retentate and a serum-rich fraction as permeate, followed by concentrating said serum-rich fraction by ultrafiltration using a 5-10 kDa membrane, said microfiltration and ultrafiltration being carried out at a temperature in the range of 10-20°C, preferably 10-15°C, most preferably 10-12°C.
4. The microfiltration and ultrafiltration are carried out at 5000 to 8000 m 2 , preferably 5200 to 7500 m 2 , more preferably 5400 to 7000 m 2 , most preferably 5400 to 6600 m 2 Or 6200 to 7000 m 2 The process of claim 3, carried out using a total membrane surface area in the range of
5. 5. The process according to claim 3 or 4, wherein the operating pressure during the microfiltration varies in the range of 0.8 to 3.5 bar, preferably 0.8 to 3.0 bar, more preferably 0.8 to 2.5 bar, even more preferably 0.8 to 2.0 bar, more preferably 0.8 to 1.5 bar and most preferably 0.8 to 1.3 bar.
6. 6. The process according to any one of claims 3 to 5, wherein the operating pressure during the ultrafiltration varies in the range of 3.5 to 5.2 bar, preferably 3.5 to 5.0 bar, more preferably 3.5 to 4.5 bar, most preferably 3.5 to 4.0 bar.
7. The flux over the membrane, i.e. the ratio between the product flow rate and the membrane surface area, is between 2 and 30 l / m 2 / h, preferably 2 to 10 l / m 2 The process according to any one of claims 3 to 6, wherein the reaction time is in the range of 100-1500 s / hour.
8. The process according to any one of claims 3 to 7, wherein the transmembrane pressure during microfiltration is in the range of 0 to 4.0 bar, preferably 0.8 to 3.5 bar, most preferably 0.8 to 1.3 bar.
9. The process according to any one of claims 3 to 8, wherein the transmembrane pressure during microfiltration is in the range of 0 to 6.0 bar, preferably 3.5 to 5.0 bar, most preferably 3.5 to 4.0 bar.
10. 1. A method for the production of a formula which requires the incorporation of one or more amino acid sources, at least one of which is a serum protein concentrate as described in claim 1, and wherein at least 90% by weight, preferably at least 95% by weight, more preferably at least 99% by weight and most preferably 100% by weight of the total amino acid content of the formula is obtained from the serum protein concentrate as described in claim 1.
11. 11. The method according to claim 10, wherein the formula has a protein content of at most 2.3 g protein / 100 kcal, preferably at most 2.2 g protein / 100 kcal, more preferably at most 2.1 g protein / 100 kcal, even more preferably at most 2.0 g protein / 100 kcal, more preferably at most 1.9 g protein / 100 kcal.
12. The formula has the following amino acid composition: - L-methionine and L-cysteine with a combined concentration of at least 61 mg / 100 kcal, preferably in the range of 90-110 mg / 100 kcal, most preferably 100-110 mg / 100 kcal L-tyrosine and L-phenylalanine with a combined concentration of at least 156 mg / 100 kcal, preferably in the range of 159-180 mg / 100 kcal, most preferably 160-170 mg / 100 kcal - at least 40 mg / 100 kcal, preferably 40-60 mg / 100 kcal, more preferably 45-55 mg / 100 kcal L-histidine - at least 90 mg / 100 kcal, preferably 93-140 mg / 100 kcal, more preferably 100-140 mg / 100 kcal of L-isoleucine - at least 166 mg / 100 kcal, preferably 190-280 mg / 100 kcal, more preferably 230-280 mg / 100 kcal L-leucine at least 113 mg / 100 kcal, preferably 155-235 mg / 100 kcal, more preferably 180-235 mg / 100 kcal L-lysine - at least 77 mg / 100 kcal, preferably 77-120 mg / 100 kcal, more preferably 95-120 mg / 100 kcal L-threonine - at least 32 mg / 100 kcal, preferably 32-48 mg / 100 kcal, more preferably 40-48 mg / 100 kcal of L-tryptophan at least 88 mg / 100 kcal, preferably 90-140 mg / 100 kcal, more preferably 110-140 mg / 100 kcal L-valine 12. The method according to claim 10 or 11, comprising:
13. 13. The method according to claim 12, wherein the formula has an L-methionine content of at least 23 mg / 100 kcal, preferably at least 40 mg / 100 kcal, and an L-cysteine content of at least 38 mg / 100 kcal, preferably at least 50 mg / 100 kcal.
14. The method according to claim 12 or 13, wherein the L-phenylalanine content of the formula is at least 81 mg / 100 kcal, preferably between 81 and 90 mg / 100 kcal, and the L-tyrosine content is at least 75 mg / 100 kcal, preferably between 75 and 85 mg / 100 kcal.
15. 15. The method according to any one of claims 10 to 14, wherein the formula has a whey protein:casein weight ratio in the range of from 70:30 to 90:10, preferably from 75:25 to 85:15, most preferably from 77:23 to 83:17.
Citation Information
Patent Citations
Novel fourth-generation infant formula and preparation method thereof
CN104351356A
Functional serum protein products for use in infant foods and therapeutic compositions, and methods for preparing the same.
JP2010524462A
Method for preparing serum protein concentrates
JP2015524668A
Process for the humanization of animal skim milk and products obtained thereby
US20150093490A1
Method for producing a milk product
WO2013068653A2
